ad image

Phase I Trial

1 / 1
Anixa Biosciences
Phase I Trial

Anixa Biosciences Announces the Initiation of its Ovarian Cancer CAR-T Phase I Trial at Moffitt Cancer Center

Anixa Biosciences

PR-M03-22-17Mar 30, 2022
Promentis Pharmaceuticals
Clinical Trial

Promentis Pharmaceuticals Announces Successful Completion of Phase 1 Studies for SXC-2023 Targeting Novel Glutamatergic Mechanism

Promentis Pharmaceuticals

PR-M11-18-NI-084Nov 23, 2018
Bio-Thera Solutions
Phase I Trial

Bio-Thera Solutions Initiates Phase I Clinical Trial for BAT-1806, a Proposed Biosimilar of Actemra® (Tocilizumab)

Bio-Thera Solutions

PR-M07-18-NI-101Jul 30, 2018
1 / 1